Saturday 17 October 2026
Export MED’s income statement to Excel — free account
MEDIFAST INC
MED Consumer Cyclical Personal Services
MEDIFAST INC’s revenue for fiscal 2025 (year ended December 2025) was $385.8 million, down 36.0% from fiscal 2024. In the quarter to June 2026, revenue fell 27.6%, EPS fell 221.7% and free cash flow grew 115.3%, each against the same quarter a year earlier. Dividend growth for five consecutive years; insiders bought in the last twelve months.
11.88
0.18
−1.49%
Follow MED
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 683.50 |
+8 more quarters Free account |
P/S ratio |
0.37 | 0.32 | 0.30 | 0.35 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
69.62 | 431.35 | (22.22) | 12.40 | |
P/B ratio |
0.60 | 0.57 | 0.59 | 0.70 | |
Price to Tangible BV |
0.60 | 0.57 | 0.59 | 0.70 | |
EV/Sales |
(0.04) | (0.05) | (0.03) | 0.04 | |
EV/EBITDA |
2.09 | 7.47 | 17.88 | 2.02 | |
EV/Operating CF |
(1.50) | (4.92) | (1.67) | 2.12 | |
EV/FCF |
0.68 | 0.74 | 0.45 | (0.58) | |
Quick Ratio |
4.21 | 4.13 | 4.01 | 3.71 | |
Current Ratio |
4.86 | 4.80 | 4.69 | 4.45 | |
Net Debt/EBITDA |
164.71 | (7,039.42) | 37.21 | 220.75 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
1.20 | 1.30 | 1.45 | 1.54 | |
Operating CF/Net income |
(0.55) | (0.12) | 0.29 | (5.36) | |
Capex/Depreciation |
(0.29) | 0.77 | (0.41) | (0.41) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
75.57% | 72.39% | 79.82% | 74.09% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
2.38% | 2.49% | 2.89% | 1.02% | |
Graham Net Nets |
1.17 | 1.32 | 1.30 | 1.03 | |
Graham Number |
0.00 | 0.00 | 0.00 | 2.96 | |
Earnings Yield |
(21.96%) | (17.86%) | (15.92%) | 0.15% | |
Free Cash Flow Yield |
(16.35%) | (22.11%) | (21.93%) | (17.52%) | |
Revenue per Share |
6.86 | 6.91 | 6.84 | 8.13 | |
Operating CF per Share |
0.15 | 0.02 | (0.48) | 1.10 | |
Capex per Share |
(0.09) | 0.23 | (0.12) | (0.12) | |
Free Cash Flow per Share |
0.07 | 0.25 | (0.60) | 0.98 | |
Cash per Share |
15.25 | 15.35 | 15.23 | 15.79 | |
Shareholders Equity per Share |
17.64 | 17.96 | 18.11 | 19.53 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
17.64 | 17.96 | 18.11 | 19.53 | |
Free Cash Flow |
0.73 | 2.80 | (6.63) | 10.75 | |
Working Capital |
160.47 | 160.45 | 158.72 | 161.13 | |
Capital Expenditures |
(0.97) | 2.54 | (1.35) | (1.36) | |
Net Current Asset Value |
138.01 | 148.27 | 152.63 | 154.34 | |
EV/EBIT |
0.67 | 1.12 | 0.81 | 0.00 | |
Capex to Sales |
0.01 | (0.03) | 0.02 | 0.02 | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
2.67 | 2.95 | 2.88 | — | |
Average Payables |
38.33 | 45.04 | 47.43 | 53.76 | |
Average Inventory |
25.69 | 30.38 | 31.32 | 31.65 | |
Average Assets |
264.87 | 266.03 | 266.09 | 279.72 | |
Average Common Equity |
206.19 | 204.32 | 204.51 | 211.02 |
Columns are period end dates